rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Pro-Dex, Inc.

PDEX · Nasdaq

Health CareMedical DevicesJust dropped out

PDEX stood above a rising 150-day average in 29 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 3.2% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$4.1M
Officials’ trades on record
0
Institutions holding
65 (+9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 29 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$2.6M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months6
Buyers · sellers0 · 3
WhoDidSharesTraded
Kirk Richard Lee Van, Jr.Chief Executive Officersold290at $58.9411 Sep 2026filed 14 Sep 2026
Kirk Richard Lee Van, Jr.Chief Executive Officersold475at $59.6211 Sep 2026filed 14 Sep 2026
Alisha CharltonChief Financial Officersold1,500at $61.059 Sep 2026filed 10 Sep 2026
Alisha CharltonChief Financial Officersold800at $61.769 Sep 2026filed 10 Sep 2026
Kirk Richard Lee Van, Jr.Chief Executive Officersold2,160at $58.929 Sep 2026filed 10 Sep 2026
Kirk Richard Lee Van, Jr.Chief Executive Officersold2,691at $59.849 Sep 2026filed 10 Sep 2026
Kirk Richard Lee Van, Jr.Chief Executive Officersold4,274at $60.729 Sep 2026filed 10 Sep 2026
Kirk Richard Lee Van, Jr.Chief Executive Officersold1,157at $61.889 Sep 2026filed 10 Sep 2026
Kirk Richard Lee Van, Jr.Chief Executive Officersold935at $62.939 Sep 2026filed 10 Sep 2026
Kirk Richard Lee Van, Jr.Chief Executive Officersold2,144at $63.859 Sep 2026filed 10 Sep 2026
Kirk Richard Lee Van, Jr.Chief Executive Officersold300at $64.709 Sep 2026filed 10 Sep 2026
Kirk Richard Lee Van, Jr.Chief Executive Officersold806at $58.669 Sep 2026filed 10 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders65+9 on the quarter
New · exited16 · 7
Reported value$42.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 2026153,178$9.0M+663+0.4%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 202682,283$4.8M-29,047−26.1%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 202657,061$3.3M+120+0.2%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.reduced · filed 14 Aug 202652,735$3.1M-9,000−14.6%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202649,636$2.9M+1,289+2.7%
JPMORGAN CHASE & COnew · filed 12 Aug 202632,287$1.9M+32,287
STATE STREET CORPreduced · filed 7 Aug 202631,310$1.8M-1,804−5.4%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 202618,711$1.1M+8,570+84.5%
Pekin Hardy Strauss, Inc.new · filed 30 Jul 202616,500$966K+16,500
BNP PARIBAS FINANCIAL MARKETSadded · filed 13 Aug 202615,945$934K+2,711+20.5%
31 Mar 2023 – 30 Jun 2026
194163Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Richard Lee Van Kirk Jr. Company insiderChief Executive Officer · last 11 Sep 20263 · 9
Alisha Charlton Company insiderChief Financial Officer · last 9 Sep 20260 · 6
Angelita Rebamontan Domingo Company insiderDirector · last 23 Jul 20260 · 2
Katrina Marie Kramer Philp Company insiderDirector · last 21 Nov 20253 · 0
David Hovda Company insiderDirector · last 20 Nov 20250 · 4
Nicholas John Swenson Company insiderDirector, 10% owner · last 20 Nov 202563 · 8
Raymond E. Cabillot Company insiderDirector, 10% owner · last 20 Nov 202529 · 28
William James Farrell III Company insiderDirector · last 20 Nov 20253 · 2
Farnam Street Partners Lp /mn Company insider10% owner · last 20 Mar 20252 · 24
Ao Partners I, Lp Company insider10% owner · last 15 Dec 20204 · 1
Harold A. Hurwitz Company insiderCEO, PRES, CFO, SEC, TREAS · last 30 Apr 20141 · 0
William L. Healey Company insiderDirector · last 4 Feb 20130 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2026 · to 30 Jun 202631.4%
Operating profit marginFY 2026 · to 30 Jun 202616.8%
Free cash flow marginFY 2026 · to 30 Jun 20268.7%
Return on capital employedFY 2026 · to 30 Jun 202621.1%
Cash conversionFY 2026 · to 30 Jun 202653.0%
Debt to equityFY 2026 · to 30 Jun 20260.37×
Research spendFY 2026 · to 30 Jun 20264.3%
Share count trendFY 2026 · to 2 Sep 20260.5%
Cash and equivalentsFY 2026 · to 30 Jun 2026$8.2M
Free cash flowFY 2026 · to 30 Jun 2026$6.8M

Analyst forecasts

No analyst forecasts yet.